AMARIN CORP PLC\UK Increase (Decrease) in Interest Payable, Net
AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Interest Payable, Net of -$428.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2023-03-01
- AMARIN CORP PLC\UK increase (decrease) in interest payable, net for the quarter ending 2020-12-31 was -$80.00K.
- AMARIN CORP PLC\UK increase (decrease) in interest payable, net for the quarter ending 2020-09-30 was -$108.00K.
- AMARIN CORP PLC\UK increase (decrease) in interest payable, net for the quarter ending 2020-06-30 was -$129.00K.
- AMARIN CORP PLC\UK increase (decrease) in interest payable, net for the quarter ending 2020-03-31 was -$111.00K.
- AMARIN CORP PLC\UK increase (decrease) in interest payable, net for fiscal 2020 was -$428.00K.
- AMARIN CORP PLC\UK increase (decrease) in interest payable, net for fiscal 2019 was -$210.00K.
- AMARIN CORP PLC\UK increase (decrease) in interest payable, net for fiscal 2018 was -$310.00K.
- AMARIN CORP PLC\UK increase (decrease) in interest payable, net for fiscal 2017 was -$6.49M.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 9 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|---|
| 2020-12-31 | -$80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$188.00K derived: sum of 2 quarters · filed 2023-03-01 | -$317.00K derived: sum of 3 quarters · filed 2023-03-01 | -$428.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | -$108.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$237.00K derived: sum of 2 quarters · filed 2021-11-03 | -$348.00K 10-Q · filed 2021-11-03 | -$413.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$129.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$240.00K 10-Q · filed 2021-08-05 | -$305.00K derived: sum of 3 quarters · filed 2022-03-01 | -$369.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$111.00K 10-Q · filed 2021-04-29 | -$176.00K derived: sum of 2 quarters · filed 2022-03-01 | -$240.00K derived: sum of 3 quarters · filed 2022-03-01 | -$248.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$129.00K derived: sum of 2 quarters · filed 2022-03-01 | -$137.00K derived: sum of 3 quarters · filed 2022-03-01 | -$210.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$72.00K derived: sum of 2 quarters · filed 2020-11-05 | -$145.00K 10-Q · filed 2020-11-05 | -$84.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$81.00K 10-Q · filed 2020-08-04 | -$20.00K derived: sum of 3 quarters · filed 2021-02-25 | -$333.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$73.00K 10-Q · filed 2020-04-30 | -$12.00K derived: sum of 2 quarters · filed 2021-02-25 | -$325.00K derived: sum of 3 quarters · filed 2021-02-25 | -$56.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$252.00K derived: sum of 2 quarters · filed 2021-02-25 | $17.00K derived: sum of 3 quarters · filed 2021-02-25 | -$310.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | -$313.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$44.00K derived: sum of 2 quarters · filed 2019-11-05 | -$371.00K 10-Q · filed 2019-11-05 | $97.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$58.00K 10-Q · filed 2019-07-31 | $410.00K derived: sum of 3 quarters · filed 2020-02-25 | -$2.72M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$327.00K 10-Q · filed 2019-05-01 | $141.00K derived: sum of 2 quarters · filed 2020-02-25 | -$2.99M derived: sum of 3 quarters · filed 2020-02-25 | -$4.55M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $468.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$2.66M derived: sum of 2 quarters · filed 2020-02-25 | -$4.22M derived: sum of 3 quarters · filed 2020-02-25 | -$6.49M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$4.69M derived: sum of 2 quarters · filed 2018-11-01 | -$6.96M 10-Q · filed 2018-11-01 | -$8.43M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$3.83M 10-Q · filed 2018-08-01 | -$5.30M derived: sum of 3 quarters · filed 2019-02-27 | -$8.62M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$2.27M 10-Q · filed 2018-05-02 | -$3.74M derived: sum of 2 quarters · filed 2019-02-27 | -$7.06M derived: sum of 3 quarters · filed 2019-02-27 | -$6.46M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$4.79M derived: sum of 2 quarters · filed 2019-02-27 | -$4.19M derived: sum of 3 quarters · filed 2019-02-27 | -$6.21M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$3.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$2.71M derived: sum of 2 quarters · filed 2017-11-01 | -$4.73M 10-Q · filed 2017-11-01 | -$3.98M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $599.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$1.42M 10-Q · filed 2017-08-02 | -$669.00K derived: sum of 3 quarters · filed 2018-02-27 | -$2.08M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$2.02M 10-Q · filed 2017-05-03 | -$1.27M derived: sum of 2 quarters · filed 2018-02-27 | -$2.68M derived: sum of 3 quarters · filed 2018-02-27 | -$1.38M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $747.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$663.00K derived: sum of 2 quarters · filed 2018-02-27 | $640.00K derived: sum of 3 quarters · filed 2018-02-27 | -$652.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$107.00K derived: sum of 2 quarters · filed 2016-11-03 | -$1.40M 10-Q · filed 2016-11-03 | $205.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $11.00K 10-Q · filed 2016-08-04 | $1.61M derived: sum of 3 quarters · filed 2017-03-01 | $735.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$1.29M 10-Q · filed 2016-05-05 | $312.00K derived: sum of 2 quarters · filed 2017-03-01 | -$568.00K derived: sum of 3 quarters · filed 2017-03-01 | $1.53M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $724.00K derived: sum of 2 quarters · filed 2017-03-01 | $2.83M derived: sum of 3 quarters · filed 2017-03-01 | $2.42M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$880.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $1.22M derived: sum of 2 quarters · filed 2015-11-04 | $816.00K 10-Q · filed 2015-11-04 | $2.89M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $1.70M 10-Q · filed 2015-08-06 | $3.77M derived: sum of 3 quarters · filed 2016-02-25 | $5.12M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$405.00K 10-Q · filed 2015-05-08 | $1.67M derived: sum of 2 quarters · filed 2016-02-25 | $3.01M derived: sum of 3 quarters · filed 2016-02-25 | $7.92M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $2.07M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $3.42M derived: sum of 2 quarters · filed 2016-02-25 | $8.33M derived: sum of 3 quarters · filed 2016-02-25 | $10.45M 10-K · filed 2016-02-25 |
| 2013-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $6.26M derived: sum of 2 quarters · filed 2014-08-07 | $8.38M 10-Q · filed 2013-11-07 | $9.81M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $4.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $7.04M 10-Q · filed 2014-08-07 | $8.46M derived: sum of 3 quarters · filed 2015-03-03 | $7.05M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $2.12M 10-Q · filed 2014-05-09 | $3.55M derived: sum of 2 quarters · filed 2015-03-03 | $2.14M derived: sum of 3 quarters · filed 2015-03-03 | $3.45M derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $12.00K derived: sum of 2 quarters · filed 2015-03-03 | $1.32M derived: sum of 3 quarters · filed 2015-03-03 | $2.52M 10-K · filed 2015-03-03 |
| 2012-09-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$102.00K derived: sum of 2 quarters · filed 2013-11-07 | $1.09M 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $2.51M 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | $1.20M 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |